
Pramukh Swami Pharma Limited
Pharmaceutical company manufacturing various products under WHO standards since 1997.
Pharmaceutical company manufacturing various products under WHO standards since 1997.
Pramukh Swami Pharma Limited (PSPL) is a Public Limited Indian Non-Government Company incorporated in India on 15 May 1997 and has a history of 27 years and nine months. Its registered office is in Gandhi Nagar, Gujarat, India.
The Corporate was formerly known as Pramukh Swami Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹49.39 Cr. The company has closed loans amounting to ₹2.68 M, as per Ministry of Corporate Affairs (MCA) records.
Dineshkumar Navadiya, Yashvantray Bhalani, Vasantiben Bhalani, and One other member serve as directors at the Company.
Gandhi Nagar, Gujarat, India
+91-XXXXXXXXXX
-
U24231GJ1997PLC032344
032344
Public Limited Indian Non-Government Company
15 May 1997
30 Sep 2024
31 Mar 2024
Unlisted
Roc Ahmedabad
Pramukh Swami Pharma Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Gastrointestinal Drugs, Cardiovascular Drugs & Medication, Kidney Drugs.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Yashvantray Bhalani ![]() | Managing Director | 01-Apr-1998 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shyamal Bhalani ![]() | Director | 12-Mar-2008 | Current |
Dineshkumar Navadiya ![]() | Director | 14-Oct-2002 | Current |
Vasantiben Bhalani ![]() | Director | 15-May-1997 | Current |
Pramukh Swami Pharma Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 30.59% increase. The company also saw a substantial fall in profitability, with a 64.8% decrease in profit. The company's net worth moved up by a moderate rise of 3.9%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2021, Pramukh Swami Pharma had a promoter holding of 91.10% and a public holding of 8.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Dineshkumar Navadiya is a mutual person
Dineshkumar Navadiya is a mutual person
Dineshkumar Navadiya is a mutual person
Dineshkumar Navadiya is a mutual person
Dineshkumar Navadiya is a mutual person
Dineshkumar Navadiya is a mutual person
₹493.87 M
₹2.68 M
Date | Lender | Amount | Status |
---|---|---|---|
09 May 2024 | Bank Of India | ₹24.29 Cr | Open |
25 Sep 2023 | Others | ₹2.50 M | Open |
09 Oct 2015 | Bank Of India | ₹4.50 M | Open |
15 Apr 2003 | Bank Of India | ₹1.00 Cr | Open |
18 Mar 2002 | Bank Of India | ₹23.40 Cr | Open |
Pramukh Swami Pharma has a workforce of 4 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Pramukh Swami Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pramukh Swami Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Pramukh Swami Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
A charge with Bank Of India amounted to Rs. 242.90 M with Charge ID 100932769 was registered on 09 May 2024.
A charge with Bank Of India of Rs. 233.97 M registered on 18 Mar 2002 with Charge ID 90105149 was modified on 09 May 2024.
Pramukh Swami Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
A charge with Others amounted to Rs. 2.50 M with Charge ID 100803525 was registered on 25 Sep 2023.
A charge with Bank Of India of Rs. 10.00 M registered on 15 Apr 2003 with Charge ID 90104198 was modified on 25 Aug 2022.
Pramukh Swami Pharma Limited was incorporated on 15 May 1997.
The authorized share capital of Pramukh Swami Pharma Limited is ₹ 5.00 M and paid-up capital is ₹ 5.00 M.
Currently 4 directors are associated with Pramukh Swami Pharma Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Pramukh Swami Pharma Limited is Block No. 1185/A Near Shah Alloys Nasmed Road Village Santej, Ta. Kalol India, Gandhinagar, Gujarat, 382721.
The corporate identification number (CIN) of Pramukh Swami Pharma Limited is U24231GJ1997PLC032344 and the company number is 032344 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Pramukh Swami Pharma Limited has risen by 30.59%.
As Per 2022 financial reports, 4 employees are currently employed by Pramukh Swami Pharma Limited.
The financial reports for the fiscal year 2022 indicates that The net worth of Pramukh Swami Pharma Limited has experienced an upsurge of 3.90%.
As per the financial statements for fiscal Year 2022, The total open charges for Pramukh Swami Pharma Limited amount to ₹ 49.39 Cr.
The most recent Balance Sheet for Pramukh Swami Pharma Limited was filed with the ROC on 31 Mar 2024.
RP
DN
CS